ILA 572.1
(1.62%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -35.88 Million | -34.5 Million | -22.75 Million | -28.32 Million | -27.88 Million | -13.29 Million |
Net Income | -18.75 Million | -33.69 Million | -34.2 Million | -29.69 Million | -27.33 Million | -22.59 Million |
Depreciation & Amortization | 476 Thousand | 482 Thousand | 461 Thousand | 715 Thousand | 989 Thousand | 1.39 Million |
Deferred income taxes | -172 Thousand | - | - | -12 Thousand | -135 Thousand | - |
Stock-based compensation | 3.55 Million | 4.32 Million | 4.27 Million | 2.77 Million | 2.4 Million | 2.16 Million |
Change in working capital | -20.7 Million | -5.55 Million | 6.82 Million | -2.28 Million | -3.79 Million | 5.65 Million |
Other non-cash items | -280 Thousand | -69 Thousand | -104 Thousand | 184 Thousand | -22 Thousand | 98 Thousand |
Investing Cash Flow | 35.51 Million | 37.06 Million | 6.61 Million | -82.17 Million | 5.33 Million | -35.15 Million |
Investments in PPE | -172 Thousand | -487 Thousand | -292 Thousand | -166 Thousand | -155 Thousand | -158 Thousand |
Acquisitions | -35.68 Million | - | - | - | - | - |
Investment purchases | -53.7 Million | -76.9 Million | -129.94 Million | -152.35 Million | -54.3 Million | -62.4 Million |
Sales/Maturities of investments | 89.38 Million | 114.44 Million | 136.85 Million | 70.3 Million | 59.4 Million | 27.4 Million |
Other Investing Activities | 35.68 Million | 2000.00 | 3000.00 | 44 Thousand | 382 Thousand | 2000.00 |
Financing Cash Flow | 3.08 Million | 353 Thousand | 16.83 Million | 108.46 Million | 25.93 Million | 28.39 Million |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 3.08 Million | - | 14.95 Million | 74.14 Million | 22.75 Million | 27.71 Million |
Other Financing Activities | 3.08 Million | 353 Thousand | 1.88 Million | 34.31 Million | 3.17 Million | 685 Thousand |
Accounts receivables | -61 Million | - | 2 Million | -2 Million | -142 Thousand | - |
Accounts payables | - | -1.6 Million | 3.36 Million | 3.81 Million | - | - |
Inventory | - | - | -3.36 Million | -3.81 Million | - | - |
Other working capital | 40.29 Million | -3.95 Million | 4.82 Million | -281 Thousand | -3.64 Million | 5.65 Million |
Cash at beginning of period | 11.42 Million | 8.51 Million | 7.81 Million | 9.83 Million | 6.46 Million | 26.52 Million |
Cash at end of period | 14.25 Million | 11.42 Million | 8.51 Million | 7.81 Million | 9.83 Million | 6.46 Million |
Capital Expenditure | -172 Thousand | -487 Thousand | -292 Thousand | -166 Thousand | -155 Thousand | -158 Thousand |
Effect of forex changes on cash | 129 Thousand | -393 Thousand | -59 Thousand | - | - | - |
Net cash flow / Change in cash | 2.83 Million | 2.9 Million | 704 Thousand | -2.02 Million | 3.37 Million | -20.05 Million |
Free Cash Flow | -36.05 Million | -34.99 Million | -23.04 Million | -28.48 Million | -28.04 Million | -13.44 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -2.12 Million | -7.26 Million | -18.75 Million | 9.71 Million | -9.85 Million | -9.27 Million |
Depreciation & Amortization | - | - | 476 Thousand | - | - | - |
Deferred income taxes | - | - | -172 Thousand | - | - | - |
Stock-based compensation | - | - | 3.55 Million | 3.55 Million | - | - |
Change in working capital | - | - | -20.7 Million | - | - | - |
Other non-cash items | 2.12 Million | 7.26 Million | -280 Thousand | -13.26 Million | 9.85 Million | 9.27 Million |
Investing Cash Flow | - | - | 35.51 Million | - | - | - |
Investments in PPE | - | - | -172 Thousand | - | - | - |
Acquisitions | - | - | -35.68 Million | - | - | - |
Investment purchases | - | - | -53.7 Million | - | - | - |
Sales/Maturities of investments | - | - | 89.38 Million | - | - | - |
Other Investing Activities | - | - | 35.68 Million | - | - | - |
Financing Cash Flow | - | - | 3.08 Million | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | 3.08 Million | - | - | - |
Other Financing Activities | - | - | 3.08 Million | - | - | - |
Accounts receivables | - | - | -61 Million | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | 40.29 Million | - | - | - |
Cash at beginning of period | - | - | 11.42 Million | - | - | - |
Cash at end of period | - | - | 14.25 Million | - | - | - |
Capital Expenditure | - | - | -172 Thousand | - | - | - |
Effect of forex changes on cash | - | - | 129 Thousand | - | - | - |
Net cash flow / Change in cash | - | - | 2.83 Million | - | - | - |
Free Cash Flow | - | - | -36.05 Million | - | - | - |
300425
SYNGENE
SSOF
300248
CSNVF
688639